YAP1 and heart failure: Both pharmacological and genetic interventions targeting the YAP-TEAD pathway mitigate heart failure exacerbation induced by pressure overload in these models, indicating that YAP and TEAD are promising therapeutic targets for preventing cardiac dysfunction in HFpEF patients experiencing metabolic and concomitant mechanical stress overload200.